Telepharmacy Patent Erroneously Declared Nonobvious, Panel Says
WASHINGTON, D.C. — In a May 28 holding, the Federal Circuit U.S. Court of Appeals reversed and remanded findings by the Patent Trial and Appeal Board that various challenged claims of...To view the full article, register now.
Already a subscriber? Click here to view full article